azathioprine
FDA Approved, EMA Approved
Description
Azathioprine is an immunosuppressive antimetabolite that interferes with DNA synthesis and cell proliferation. It is used as a steroid-sparing agent in autoimmune pancreatitis and vasculitis. The drug is metabolized to 6-mercaptopurine and exerts its immunosuppressive effects primarily on T-lymphocytes.
Indications & Therapeutic Use
autoimmune pancreatitis, vasculitis, immunosuppression
Global Availability (10 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — |
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
azathioprine
| Generic Name | azathioprine |
| Brands | 1 brand available |
| Active Ingredient | azathioprine |
| Drug Class | autoimmune pancreatitis |
| Manufacturer | Aspen/Multiple manufacturers |
| Dosage Forms | Oral tablets 25mg, 50mg, 75mg, 100mg |
| Medical Code | L04AX01 |
| Orphan Status | No |
| Cold Chain | Not Required |
| Lead Time | 3 days |
| Reg. Status | FDA Approved, EMA Approved |
| Countries | 10 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations11 Validated Nodes